India calls for IP waiver to combat COVID-19

The Indian government has called upon members of the WTO to deliver on its proposal to waive IP obligations in order to deal more effectively with the COVID-19 pandemic.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Asia

India approves COVID-19 vaccines ahead of huge rollout

5 January 2021 India has granted emergency approval to COVID-19 vaccines developed by AstraZeneca and Oxford University and one from the state-run institute Bharat Biotech, ahead of a huge immunisation drive that is planned to begin this week.

Big Pharma

WHO head calls for IP waiver to beat COVID-19

9 March 2021 The director general of the World Health Organization has called for a waiver on IP rights to ensure more equitable access to COVID-19 vaccines.

Big Pharma

AIPPI weighs in on COVID waiver

17 May 2021 The International Association for the Protection of Intellectual Property has released a position paper on the proposed COVID-19 IP waiver, claiming that it will have a negative impact on the existing frameworks for promoting international cooperation and access to vaccines.

More on this story

Asia

India approves COVID-19 vaccines ahead of huge rollout

Big Pharma

WHO head calls for IP waiver to beat COVID-19

9 March 2021 The director general of the World Health Organization has called for a waiver on IP rights to ensure more equitable access to COVID-19 vaccines.

Big Pharma

AIPPI weighs in on COVID waiver

More on this story

Asia

India approves COVID-19 vaccines ahead of huge rollout

Big Pharma

WHO head calls for IP waiver to beat COVID-19

9 March 2021 The director general of the World Health Organization has called for a waiver on IP rights to ensure more equitable access to COVID-19 vaccines.

Big Pharma

AIPPI weighs in on COVID waiver